GB0302431D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0302431D0
GB0302431D0 GBGB0302431.2A GB0302431A GB0302431D0 GB 0302431 D0 GB0302431 D0 GB 0302431D0 GB 0302431 A GB0302431 A GB 0302431A GB 0302431 D0 GB0302431 D0 GB 0302431D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0302431.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0302431.2A priority Critical patent/GB0302431D0/en
Publication of GB0302431D0 publication Critical patent/GB0302431D0/en
Priority to PCT/EP2004/000954 priority patent/WO2004067502A1/en
Priority to JP2006501711A priority patent/JP2006516588A/ja
Priority to US10/543,974 priority patent/US20060247271A1/en
Priority to EP04706684A priority patent/EP1599444A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
GBGB0302431.2A 2003-01-30 2003-01-30 Novel compounds Ceased GB0302431D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0302431.2A GB0302431D0 (en) 2003-01-30 2003-01-30 Novel compounds
PCT/EP2004/000954 WO2004067502A1 (en) 2003-01-30 2004-01-30 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23
JP2006501711A JP2006516588A (ja) 2003-01-30 2004-01-30 Ｓ−ｃｄ２３のインヒビターとしてのスルホニルヒドロキサム酸誘導体
US10/543,974 US20060247271A1 (en) 2003-01-30 2004-01-30 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23
EP04706684A EP1599444A1 (en) 2003-01-30 2004-01-30 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0302431.2A GB0302431D0 (en) 2003-01-30 2003-01-30 Novel compounds

Publications (1)

Publication Number Publication Date
GB0302431D0 true GB0302431D0 (en) 2003-03-05

Family

ID=9952325

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0302431.2A Ceased GB0302431D0 (en) 2003-01-30 2003-01-30 Novel compounds

Country Status (5)

Country Link
US (1) US20060247271A1 (https=)
EP (1) EP1599444A1 (https=)
JP (1) JP2006516588A (https=)
GB (1) GB0302431D0 (https=)
WO (1) WO2004067502A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010032147A2 (en) * 2008-09-19 2010-03-25 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
DK2512474T3 (en) 2009-12-16 2014-12-01 Pfizer N-linked hydroxamic acid derivatives which can be used as antibacterial agents
MA34963B1 (fr) 2011-03-07 2014-03-01 Pfizer Derives de fluoro-pyridinone utiles en tant qu'agents antibacteriens
CA2830866A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
WO2012137094A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047874A1 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
DE60107240T2 (de) * 2000-05-25 2005-04-14 Smithkline Beecham P.L.C., Brentford Bicyclyl oder heterobicyclyl methanesulfonylamino-substituierte n-hydroxyformamide
WO2002006234A1 (en) * 2000-07-17 2002-01-24 Takeda Chemical Industries, Ltd. Sulfone derivatives, process for their production and use thereof

Also Published As

Publication number Publication date
WO2004067502A1 (en) 2004-08-12
US20060247271A1 (en) 2006-11-02
EP1599444A1 (en) 2005-11-30
JP2006516588A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
EP1648885A4 (en) NEW CONNECTIONS
GB0305426D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0305292D0 (en) Novel compounds
GB0304803D0 (en) Novel compounds
GB0306203D0 (en) Novel compounds
GB0306211D0 (en) Novel compounds
GB0305722D0 (en) Novel compounds
GB0305688D0 (en) Novel compounds
GB0305687D0 (en) Novel compounds
GB0305586D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0306212D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0306213D0 (en) Novel compounds
GB0305291D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)